Octapeptin: 'Forgotten' antibiotic offers hope against worst superbugs

antibiotics
Staphylococcus aureus - Antibiotics Test plate. Credit: CDC

An antibiotic overlooked since its discovery 40 years ago could help develop new drugs against life-threatening infections caused by some of the world's most dangerous superbugs.

University of Queensland Institute for Molecular Bioscience (IMB) researchers synthesised the antibiotic, and increased its effectiveness against extensively drug-resistant bacteria, then collaborated with Monash University to evaluate the drug using animal models of infection.

Professor Matt Cooper, Director of IMB's Centre for Superbug Solutions, said the study was prompted by the urgent need for to counter widespread resistance to last-resort treatments.

"Octapeptins were discovered in the late 1970s but were not selected for development at the time, as there was an abundance of with thousands of people working in antibiotic research and development," Professor Cooper said.

"Given the very few researchers left in this field now, and the sparse pipeline for new antibiotics, we've used modern drug discovery procedures to re-evaluate its effectiveness against superbugs."

Professor Cooper said there were no new classes of antibiotics available for Gram-negative bacteria, with increasing incidence of extensive drug resistance around the world.

"Gram-negative bacteria are harder to kill as disease organisms, because they have an extra membrane to penetrate that is often hidden by a capsule or slime layer which acts to camouflage them from drugs and our immune system," he said.

"The emergence of resistance to meropenem, and now colistin, the antibiotic of last resort, means multi-drug and extensively -resistant bacteria are now a reality confronting clinicians.

"Octapeptin showed superior antimicrobial activity to colistin against extensively resistant Gram-negative bacteria in early pre-clinical testing.

"In addition, octapeptin was shown to be potentially less toxic to the kidneys than colistin."

Professor Cooper said the study laid the foundation for the development of a new generation of to treat life-threatening infections.

The study is published in Cell Chemical Biology.


Explore further

Supercharged antibiotics could turn tide against superbugs

More information: Cell Chemical Biology (2018). DOI: 10.1016/j.chembiol.2018.01.005
Journal information: Cell Chemical Biology

Citation: Octapeptin: 'Forgotten' antibiotic offers hope against worst superbugs (2018, January 25) retrieved 20 May 2019 from https://phys.org/news/2018-01-octapeptin-forgotten-antibiotic-worst-superbugs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
929 shares

Feedback to editors

User comments

Jan 25, 2018
"Sometimes, grasping at straws is all you have."

Here's hoping that Octapeptin turns out to be lethal for at least some of the 'Superbugs' and not too toxic for already compromised patients.

For at least long enough for any of the still developing new treatments and technology to become available.

Jan 25, 2018
A lot of patients infected with these superbugs are as healthy as you or me. You do not have to have a compromised immune system to be vulnerable.

I know that from personal experience. Twice.

Jan 26, 2018
Parsec, If it's not too personal-emotional traumatic for you to reveal? I will not be offended if you refuse or simply disregard my questions.

Which treatment did you have a toxic reaction to?

Were there any overlaps in superbugs and your reaction to treatment?

What are you doing differently now in your lifestyle? To try and avoid a third infection.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more